StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$2.78−0.08 (-2.80%)

Close on Nov 13, 2026Market cap $152.26MP/E –Yield –

Upstream Bio total assets

Total assets on the balance sheet at the end of each period.

Upstream Bio's total assets was $245.99M at Sep 30, 2026. For fiscal 2025 it was $353.77M, down 26.6% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$353.77M-26.6%
FY2024Dec 31, 2024$481.72M+311.0%
FY2023Dec 31, 2023$117.20M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$245.99M-37.1%
Q2 FY2026Jun 30, 2026$281.17M-33.1%
Q1 FY2026Mar 31, 2026$318.05M-30.3%
Q4 FY2025Dec 31, 2025$353.77M-26.6%
Q3 FY2025Sep 30, 2025$391.20M+68.1%
Q2 FY2025Jun 30, 2025$420.52M+258.8%
Q1 FY2025Mar 31, 2025$456.17M–
Q4 FY2024Dec 31, 2024$481.72M–
Q3 FY2024Sep 30, 2024$232.70M–
Q4 FY2023Dec 31, 2023$117.20M–

More Upstream Bio figures

See a number that looks wrong?